Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 4 Jan 23 424B3 Prospectus supplement
- 13 Dec 22 EFFECT Notice of effectiveness
- 12 Dec 22 424B3 Prospectus supplement
- 8 Dec 22 S-4/A Registration of securities issued in business combination transactions (amended)
-
29 Nov 22 S-4 Registration of securities issued in business combination transactions
ADXS similar filings
- 8 Dec 22 Registration of securities issued in business combination transactions (amended)
- 29 Nov 22 Registration of securities issued in business combination transactions
- 20 Oct 21 Registration of securities issued in business combination transactions (amended)
- 13 Oct 21 Registration of securities issued in business combination transactions (amended)
- 25 Aug 21 Registration of securities issued in business combination transactions
Filing view
External links
Exhibit 99.4
Consent of Person Named as About to Become Director
November 29, 2022
Pursuant to Rule 438 promulgated under the Securities Act of 1933, as amended, I hereby consent to my being named in the Registration Statement on Form S-4 of Advaxis, Inc., and all amendments thereto (the “Registration Statement”), and any related prospectus filed pursuant to Rule 424 promulgated under the Securities Act of 1933, as amended, as a person anticipated to become a director of Advaxis, Inc. upon completion of the merger described therein, and to the filing of this consent as an exhibit to the Registration Statement.
Sincerely,
/s/ Robert Spiegel | ||
Name: | Robert Spiegel, M.D. |